The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 31 | 69.0x | 20.1x | Below average | |
Growth | 69 | 9.4% | 5.6% | Above average | |
Quality | 43 | 3.8% | 7.6% | Near average | |
Safety | 90 | -2.0x | 0.4x | Above average | |
Capital Return | 37 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Proto Labs, Inc. is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Proto Labs, Inc. shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Proto Labs stock shows a state of extreme uncertainty and a decline in analyst coverage, as the number of analysts providing price targets dropped from 3 to only 1 analyst over the past week. This decrease in the number of opinions makes the average price target ($38.5) unrepresentative of a true consensus, especially with a significant price gap (Negative Premium) as the stock currently trades at $75.84, which far exceeds the highest recorded price target ($44).
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.